PolyPid Ltd

Overview

PolyPid Ltd is a biopharmaceutical company dedicated to developing and commercializing novel antibiotic therapies to enhance surgical outcomes. The company's proprietary PLEX technology platform allows for the controlled and prolonged release of medications directly at the target site.

Therapeutic areas

API / Drug Master Files

PolyPid Ltd holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• D-PLEX (DOXYCYCLINE/POLYMER-LIPID ENCAPSULATION MATRIX)Active2026-02-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to PolyPid Ltd in our records. PharmaTek screens the full directory against live FDA enforcement data.